Philippines: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in the Philippines

For the third consecutive year, the Philippine human and animal blood market recorded growth in sales value, which increased by X% to $X in 2021. Over the period under review, consumption continues to indicate a buoyant expansion. Over the period under review, the market hit record highs at $X in 2017; however, from 2018 to 2021, consumption stood at a somewhat lower figure.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from the Philippines

In 2021, shipments abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses decreased by -X% to X kg, falling for the second year in a row after two years of growth. Overall, exports showed a slight decline. The pace of growth appeared the most rapid in 2019 when exports increased by X%. As a result, the exports attained the peak of X kg. From 2020 to 2021, the growth of the exports remained at a somewhat lower figure.

In value terms, human and animal blood exports fell remarkably to $X in 2021. In general, exports, however, posted a modest increase. The pace of growth appeared the most rapid in 2019 when exports increased by X% against the previous year. As a result, the exports reached the peak of $X. From 2020 to 2021, the growth of the exports remained at a somewhat lower figure.

Exports by Country

South Korea (X kg) was the main destination for human and animal blood exports from the Philippines, with a X% share of total exports. Moreover, human and animal blood exports to South Korea exceeded the volume sent to the second major destination, Vietnam (X kg), threefold. The third position in this ranking was taken by Hong Kong SAR (X kg), with an X% share.

From 2012 to 2021, the average annual growth rate of volume to South Korea amounted to +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Vietnam (+X% per year) and Hong Kong SAR (+X% per year).

In value terms, the largest markets for human and animal blood exported from the Philippines were Vietnam ($X), South Korea ($X) and Indonesia ($X), together accounting for X% of total exports.

South Korea, with a CAGR of +X%, recorded the highest growth rate of the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The average human and animal blood export price stood at $X per ton in 2021, increasing by X% against the previous year. Overall, the export price saw a perceptible increase. The most prominent rate of growth was recorded in 2019 an increase of X% against the previous year. The export price peaked in 2021 and is likely to see gradual growth in the immediate term.

There were significant differences in the average prices for the major external markets. In 2021, the country with the highest price was Indonesia ($X per ton), while the average price for exports to Malaysia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Vietnam (+X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into the Philippines

In 2021, after two years of growth, there was decline in overseas purchases of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, when their volume decreased by -X% to X tons. Over the period under review, imports, however, posted a significant increase. The growth pace was the most rapid in 2013 with an increase of X%. Over the period under review, imports attained the maximum at X tons in 2016; however, from 2017 to 2021, imports failed to regain momentum.

In value terms, human and animal blood imports reached $X in 2021. Overall, imports, however, saw a prominent increase. The pace of growth was the most pronounced in 2015 with an increase of X% against the previous year. Imports peaked at $X in 2017; however, from 2018 to 2021, imports remained at a lower figure.

Imports by Country

In 2021, Spain (X tons) constituted the largest human and animal blood supplier to the Philippines, accounting for a X% share of total imports. Moreover, human and animal blood imports from Spain exceeded the figures recorded by the second-largest supplier, Germany (X tons), twofold. Switzerland (X tons) ranked third in terms of total imports with a X% share.

From 2012 to 2021, the average annual rate of growth in terms of volume from Spain amounted to +X%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (+X% per year) and Switzerland (+X% per year).

In value terms, the largest human and animal blood suppliers to the Philippines were the United States ($X), Germany ($X) and Switzerland ($X), together accounting for X% of total imports.

Germany, with a CAGR of +X%, saw the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2021, remaining relatively unchanged against the previous year. Over the period under review, the import price, however, continues to indicate a noticeable slump. The most prominent rate of growth was recorded in 2017 when the average import price increased by X%. The import price peaked at $X per ton in 2015; however, from 2016 to 2021, import prices remained at a lower figure.

Prices varied noticeably by the country of origin: the country with the highest price was Ireland ($X per ton), while the price for Spain ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by China (+X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :